NMN vs NR: What's the Difference and Which Should You Take?

If you've spent any time researching NAD+ supplements, you've almost certainly encountered two names: NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside). Both are marketed as ways to raise NAD+ levels. Both have genuine scientific interest behind them. And both are sold in broadly similar doses at broadly similar prices.

So which one should you actually take?

This guide breaks down the real differences — the biochemistry, the clinical evidence, and the practical considerations — so you can make an informed decision rather than a marketing-driven one.

What Is NAD+ and Why Does It Matter?

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every cell of the body. It plays a central role in energy metabolism — specifically in converting nutrients into ATP, the fuel your cells actually run on — and it acts as a signalling molecule for proteins involved in DNA repair and cellular stress response.

The problem is that NAD+ levels decline significantly with age. Research suggests levels in your 50s may be roughly half those in your 20s. This decline is associated with reduced cellular energy production, impaired repair mechanisms, and several hallmarks of biological ageing.

You can't simply supplement NAD+ directly — it doesn't cross cell membranes efficiently. Instead, the body builds NAD+ from precursor molecules. NMN and NR are two of the most studied of these precursors.

What Is NR (Nicotinamide Riboside)?

NR is a form of vitamin B3 first identified as an NAD+ precursor in yeast in 2004. It entered the commercial supplement market around 2013, giving it a head start in clinical research relative to NMN.

Inside the body, NR is converted to NMN — and then to NAD+. This means NR is one step further back in the biosynthesis pathway than NMN. The conversion step from NR to NMN requires an enzyme called NRK (nicotinamide riboside kinase).

Human clinical trials on NR have demonstrated it can raise blood NAD+ levels. A 2018 study in Nature Communications (Martens et al.) showed that NR supplementation at 500mg/day for six weeks increased blood NAD+ levels by approximately 60% in healthy older adults.

What Is NMN (Nicotinamide Mononucleotide)?

NMN sits one step closer to NAD+ in the biosynthesis pathway. Rather than being converted to NMN first (as NR is), it is converted directly to NAD+ via the enzyme NMNAT. This shorter route is one of the arguments made in favour of NMN's efficiency.

NMN also has a dedicated transporter in the gut — the Slc12a8 transporter — which allows some absorption directly into cells without prior conversion. This mechanism has been confirmed in mice; its relevance in humans is still being characterised, but it suggests NMN may have absorption advantages over NR in certain tissues.

Human trials on NMN have accelerated considerably since 2020. The landmark 2021 Nature Metabolism study (Yoshino et al.) demonstrated that 250mg/day of NMN improved muscle insulin sensitivity in postmenopausal women. Studies at 500mg/day have shown improvements in physical performance, fatigue scores, and biological markers of NAD+ metabolism in healthy adults.

Key Differences: Pathway, Evidence and Absorption

Biosynthesis pathway: Both NR and NMN ultimately raise NAD+. NMN requires one fewer conversion step. In practice, this may or may not produce a meaningful difference in NAD+ yield — human data directly comparing the two in the same study are limited.

Volume of human evidence: NR has a longer commercial history and a larger body of published human trials. NMN has been catching up rapidly, and recent trials are larger and more methodologically robust than the earlier NR studies.

Molecular size: NMN has a slightly larger molecular weight than NR. Earlier concerns that this might impair gut absorption have been largely addressed by the discovery of the dedicated NMN transporter and by pharmacokinetic data showing NMN does raise blood NAD+ effectively.

Tissue specificity: Some researchers have proposed that NMN may be particularly effective in liver, muscle, and brain tissue where the Slc12a8 transporter is highly expressed. NR's conversion pathway is more uniformly distributed. Whether this translates to clinically meaningful differences in specific outcomes remains an open question.

What Does the Evidence Actually Show?

Both NMN and NR reliably raise blood NAD+ levels in humans — that much is consistent across studies. The harder question is whether raising NAD+ levels translates to meaningful health outcomes, and whether one precursor is superior for specific outcomes.

Honest answer: the head-to-head evidence in humans is thin. Most trials study one compound in isolation. The comparative claims you'll see on supplement websites are largely extrapolated from mechanism, not from direct comparison trials.

What we can say:

• NR has stronger evidence in the area of cardiovascular NAD+ metabolism, with several trials in older adults and those with heart failure
• NMN has stronger recent evidence in muscle metabolism, physical performance, and insulin sensitivity
• Both appear safe at standard doses in healthy adults

Practical Considerations: Cost, Dose and Availability

On the practical side, a few differences are worth noting.

Dose: Typical NR doses in clinical trials range from 250mg to 1,000mg/day. NMN doses with demonstrated effects start at 250mg and extend to 1,000mg/day. At equivalent doses, cost per gram tends to be similar, though this varies by brand and source.

Stability: NMN is reasonably stable at room temperature but benefits from cool, dry storage. Some early NR products had stability concerns; reputable NR brands have addressed this through formulation improvements.

Regulatory status: Both are classified as food supplements in the UK and comply with MHRA guidelines. Neither is a medicine. NMN faced a brief regulatory challenge in the US market in 2022; no equivalent issue has arisen in the UK or EU.

If you're considering NMN 500mg, AlphaVita's formulation provides a full 500mg of pure beta-NMN per capsule — the upper end of the evidence-supported daily range — with no fillers or proprietary blends, and independent batch testing.

Which Should You Choose?

For most people, the honest answer is that either will likely produce a meaningful increase in NAD+ levels if taken consistently at an evidence-backed dose. The differences at the level of individual outcomes are real but not dramatic enough to be the primary deciding factor for the average user.

That said, if you're specifically interested in muscle metabolism, physical performance, and insulin sensitivity — the areas where NMN's recent human evidence is strongest — NMN is the better-evidenced choice right now.

If you're building a broader cellular energy stack, pairing NMN with CoQ10 200mg addresses mitochondrial function from two complementary angles: NMN supports NAD+ synthesis, while CoQ10 supports the electron transport chain directly. These are additive mechanisms, not redundant ones.

The Bottom Line

NMN and NR are genuine NAD+ precursors with real science behind them. NR has a longer commercial history; NMN has the more compelling recent human evidence, particularly for muscle and metabolic outcomes. Neither is a miracle — but both have a plausible, evidence-supported role in a longevity supplement protocol.

If you're deciding between the two, the current evidence favours NMN for most adults with a focus on physical performance, energy metabolism, and healthy ageing. One capsule of AlphaVita NMN 500mg daily, taken in the morning, is a sensible, evidence-backed starting point.

As always, if you have questions about how NMN fits into your specific health context, feel free to reach out at info@avlabs.bio.